The Infectious Myth Episode 5: Is Aneuploidy the Real Cancer Trigger?
March 25th, 2014

In Episode 5 of “The Infectious Myth” David’s guest is another David, Dr. David Rasnick, who has worked for almost 20 years with Peter Duesberg on the theory that aneuploidy, not gene mutations, causes cancer.

Aneuploidy refers to a cell that has the wrong number and type of chromosomes. Human cells are normally diploid, meaning that they have exactly two copies of every chromosome (except for the X and Y chromosomes that form an asymmetrical pair). According to Rasnick, every cancer tumor cell is aneuploid, often to a massive degree. On average, cancer cells have 70% more chromosomes than the cell should have.

By contrast, the mutation theory has struggled to explain cancer, having to drag in many mutations, that must occur in the same cell, in order for cancer to occur. The mutation theory does not explain why people generally get cancer later in life, if they are born with their mutations. If mutations occur later, how do they all occur in the same cell?

Rasnick discusses the history of the aneuploidy theory, going back to the 1800s. He talks about what can cause aneuploidy, and how evidence of aneuploidy is used outside the United States to define a substance as carcinogenic. He addresses claims of the discovery of diploid tumors and why he claims that these are due to either bad techniques (not looking at the cells in place in the tumor, for example) or to not realizing that even cells that are close to diploid can be aneuploid.

Check out other episodes of The Infectious Myth.

“The Infectious Myth Episode 5: Is Aneuploidy the Real Cancer Trigger?” comments…
  1. Episode 91: Dr. David Rasnick Finds No Evidence That Ebola Has Ever Been Isolated in a Human Being — Does This Sound Familiar? at How Positive Are You says:

    […] Rasnick appeared previously on HPAY, in Episodes 5 and 32, and on David Crowe’s “The Infectious Myth” program on November 18, 2014. […]

    November 20, 2014 | 9:02 am
Leave a Reply

You must be logged in to post a comment.